Gilead Sciences Nears Key Buy Level

Shares of Gilead Sciences (GILD) is pulling back after its recent surge. Since January, Gilead Sciences surged from below $57 to above $68. This massive upswing was off of multi-year lows as investors started to flood back to quality biotech names. With the stock currently pulling back, it is creating a key buy level. The pull back is known as bullish consolidation and likely will setup for the next big move higher. The buy level is a technical gap fill at $63.25. From this level, investors can expect another strong move higher to a potential high of $85.00.

(Click on image to enlarge)

Disclaimer: All comments made by InTheMoneyStocks, LLC and its subsidiaries, instructors, and representatives are for educational and informational purposes only and should not be construed as ...

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.